Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Psychiatry/Psychology
Disease Category: Bipolar Disorders
Trial Information
A Double-Blind, Placebo-Controled Trial of Olanzapine Add-On Therapy in the Treatment of Acute Syndromal and Subsyndromal Exacerbations in Bipolar Disorder
We are examining the use of olanzapine (Zyprexa) in the
treatment of patients experiencing increases in symptoms of bipolar
disorder. In this study, patients will be instructied to add
olanzapine or a placebo to their current stable medication regiment
for a period of one week, after which all patients will receive
Zyprexa for one week while being monitored by a psychiatrist using
clinical and laboratory measures.
Those eligible to participate will not be charged for taking
part in the investigation and will receive treatment at no
cost.
For additional information, please call (650) 498-4968 or visit
our website at www.bipolar.org.
Research Coordinator
Stanford University School of Medicine, Bipolar Disorders Clinic
Department of Psychiatry and Behavioral Sciences
401 Quarry Road
Stanford, CA 94305-5723
Phone: 650-498-4968
Fax: 650-723-2507
EMail: klkeller@stanford.edu
View Google Map
If you would like to learn more about participating in this study, please send an e-mail message using the form below.
DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the
clinical trials industry. The information provided in this service is designed
to help patients find clinical trials that may be of interest to them, and to
help patients contact the centers conducting the research. CenterWatch is
neither promoting this research nor involved in conducting any of these
trials.
